Table 4 Graft rejection
From: Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab
Low dose MMF | Conventional dose MMF | p1a | p2b | ||
|---|---|---|---|---|---|
Rituximab(+) | Rituximab(+) | Rituximab(−) | |||
Group 1 (n = 72) | Group 2 (n = 67) | Group 3 (n = 87) | |||
Hyperacute rejection | 0 (0 %) | 0 (0 %) | 0 (0 %) | - | - |
Acute cellular rejection | 1 (1.4 %) | 3 (4.5 %) | 9 (10.3 %) | 0.352 | 0.023 |
Antibody-mediated rejection | 2 (2.8 %) | 0 (0 %) | 0 (0 %) | 0.497 | 0.203 |
Chronic rejection | 0 (0 %) | 0 (0 %) | 1 (0.6 %) | - | 1.000 |